137 related articles for article (PubMed ID: 27430717)
1. Clonal Characteristics of Circulating B Lymphocyte Repertoire in Primary Biliary Cholangitis.
Tan YG; Wang YQ; Zhang M; Han YX; Huang CY; Zhang HP; Li ZM; Wu XL; Wang XF; Dong Y; Zhu HM; Zhu SD; Li HM; Li N; Yan HP; Gao ZH
J Immunol; 2016 Sep; 197(5):1609-20. PubMed ID: 27430717
[TBL] [Abstract][Full Text] [Related]
2. Clonal characteristics of paired infiltrating and circulating B lymphocyte repertoire in patients with primary biliary cholangitis.
Tan YG; Wang XF; Zhang M; Yan HP; Lin DD; Wang YQ; Zhang HP; Yu XQ; Liao HY; Wang YP; Lv FD; Gao ZH
Liver Int; 2018 Mar; 38(3):542-552. PubMed ID: 28834158
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
[TBL] [Abstract][Full Text] [Related]
4. Expanded circulating peripheral helper T cells in primary biliary cholangitis: Tph cells in PBC.
Yong L; Chunyan W; Yan Y; Wanyu L; Huifan J; Pingwei Z; Yanfang J
Mol Immunol; 2021 Mar; 131():44-50. PubMed ID: 33446391
[TBL] [Abstract][Full Text] [Related]
5. Profiling of the pattern of the human TRB/IGH-CDR3 repertoire in primary biliary cholangitis patients.
Han FF; Fang MX; Zhao DT; Dong YC; Yuan GH; Gao JE; Guo CL
Int Immunopharmacol; 2020 Jun; 83():106393. PubMed ID: 32353748
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis.
Tang L; Zhong R; He X; Wang W; Liu J; Zhu Y; Li Y; Hou J
J Gastroenterol Hepatol; 2017 Mar; 32(3):659-666. PubMed ID: 27529417
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for the treatment of Primary Biliary Cholangitis.
Ali AH; Tabibian JH; Carey EJ; Lindor KD
Expert Opin Emerg Drugs; 2016; 21(1):39-56. PubMed ID: 26901615
[TBL] [Abstract][Full Text] [Related]
9. Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
Tsuneyama K; Baba H; Morimoto Y; Tsunematsu T; Ogawa H
J Med Invest; 2017; 64(1.2):7-13. PubMed ID: 28373632
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
[TBL] [Abstract][Full Text] [Related]
11. Clonal accumulation of V beta 5.1-positive cells in the liver of a patient with autoimmune cholangiopathy.
Shimizu Y; Higuchi K; Kashii Y; Miyamoto M; Tsukishiro T; Watanabe A
Liver; 1997 Feb; 17(1):7-12. PubMed ID: 9062873
[TBL] [Abstract][Full Text] [Related]
12. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis.
Nakanuma Y
Hepatology; 1993 Sep; 18(3):570-5. PubMed ID: 8359797
[TBL] [Abstract][Full Text] [Related]
13. No difference in TCRβ repertoire of CD4+ naive T cell between patients with primary biliary cholangitis and healthy control subjects.
Hou X; Zeng P; Chen J; Diao H
Mol Immunol; 2019 Dec; 116():167-173. PubMed ID: 31698163
[TBL] [Abstract][Full Text] [Related]
14. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
15. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
Floreani A; Franceschet I; Cazzagon N
Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
[TBL] [Abstract][Full Text] [Related]
18. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis.
Ide T; Sata M; Nakano H; Suzuki H; Tanikawa K
Hepatogastroenterology; 1997; 44(18):1569-73. PubMed ID: 9427024
[TBL] [Abstract][Full Text] [Related]
19. VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC.
Foreman AL; Lemercier B; Lim A; Kourlisky P; Kenny T; Gershwin ME; Gougeon ML
Autoimmunity; 2008 Feb; 41(1):80-6. PubMed ID: 18176868
[TBL] [Abstract][Full Text] [Related]
20. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
